70% of HNSCC lesions respond to intratumoral anti-CTLA-4. This syngeneic HNSCC mouse model provides a platform to accelerate the development of immunotherapeutic options for HNSCC.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Wang, Z., Wu, V. H., Allevato, M. M., Gilardi, M., He, Y., Luis Callejas-Valera, J., … Gutkind, J. S. (2019). Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-13471-0